| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 7 | - | - | 1 | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - | - | - |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 224 |
| 75 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 691 |
| 220.5 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| Optic-unspecified(L) | 1,024 | 35.7% | -1.88 | 278 | 32.0% |
| CentralBrain-unspecified | 734 | 25.6% | -1.78 | 214 | 24.6% |
| PLP(L) | 648 | 22.6% | -1.51 | 227 | 26.1% |
| AME(L) | 448 | 15.6% | -1.58 | 150 | 17.3% |
| ME(L) | 15 | 0.5% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns aMe1 | % In | CV |
|---|---|---|---|---|---|
| aMe4 (L) | 9 | ACh | 200.5 | 14.3% | 0.3 |
| MeVP1 (L) | 28 | ACh | 185.5 | 13.2% | 1.1 |
| aMe6c (L) | 2 | Glu | 110.5 | 7.9% | 0.2 |
| aMe6b (L) | 1 | ACh | 90.5 | 6.5% | 0.0 |
| aMe1 (L) | 2 | GABA | 86 | 6.1% | 0.1 |
| aMe5 (L) | 18 | ACh | 84 | 6.0% | 0.7 |
| aMe3 (L) | 1 | Glu | 73.5 | 5.2% | 0.0 |
| aMe6a (L) | 1 | ACh | 59 | 4.2% | 0.0 |
| MeVPMe12 (R) | 2 | ACh | 58 | 4.1% | 0.2 |
| aMe10 (R) | 2 | ACh | 44 | 3.1% | 0.3 |
| LoVC3 (R) | 1 | GABA | 37.5 | 2.7% | 0.0 |
| aMe2 (L) | 4 | Glu | 37.5 | 2.7% | 0.7 |
| HBeyelet (L) | 4 | HA | 23 | 1.6% | 0.3 |
| aMe12 (L) | 4 | ACh | 23 | 1.6% | 0.3 |
| MeVC20 (L) | 2 | Glu | 20.5 | 1.5% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 19.5 | 1.4% | 0.0 |
| aMe30 (L) | 3 | Glu | 19 | 1.4% | 0.4 |
| MeVCMe1 (L) | 2 | ACh | 17.5 | 1.2% | 0.7 |
| MeVP11 (L) | 12 | ACh | 17.5 | 1.2% | 0.8 |
| MeVCMe1 (R) | 2 | ACh | 16 | 1.1% | 0.1 |
| MeVP49 (L) | 1 | Glu | 15 | 1.1% | 0.0 |
| PLP021 (L) | 2 | ACh | 13 | 0.9% | 0.0 |
| aMe24 (L) | 1 | Glu | 12.5 | 0.9% | 0.0 |
| AN09B023 (R) | 1 | ACh | 12 | 0.9% | 0.0 |
| aMe22 (L) | 1 | Glu | 12 | 0.9% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 12 | 0.9% | 0.0 |
| OA-AL2i3 (L) | 2 | OA | 8 | 0.6% | 0.1 |
| aMe12 (R) | 2 | ACh | 7.5 | 0.5% | 0.3 |
| PLP074 (L) | 1 | GABA | 5 | 0.4% | 0.0 |
| PLP080 (L) | 1 | Glu | 5 | 0.4% | 0.0 |
| SLP250 (L) | 1 | Glu | 5 | 0.4% | 0.0 |
| aMe23 (L) | 1 | Glu | 4.5 | 0.3% | 0.0 |
| MeLo1 (L) | 4 | ACh | 4.5 | 0.3% | 0.7 |
| LoVCLo3 (L) | 1 | OA | 4 | 0.3% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 4 | 0.3% | 0.0 |
| LoVC21 (R) | 1 | GABA | 3.5 | 0.2% | 0.0 |
| Cm20 (L) | 1 | GABA | 3 | 0.2% | 0.0 |
| aMe_unclear (L) | 1 | Glu | 3 | 0.2% | 0.0 |
| OCG02c (R) | 1 | ACh | 2.5 | 0.2% | 0.0 |
| MeVP5 (L) | 1 | ACh | 2.5 | 0.2% | 0.0 |
| MeVP31 (L) | 1 | ACh | 2.5 | 0.2% | 0.0 |
| DN1a (L) | 2 | Glu | 2 | 0.1% | 0.5 |
| MeVP33 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| LoVC25 (R) | 2 | ACh | 2 | 0.1% | 0.5 |
| SLP459 (L) | 1 | Glu | 1.5 | 0.1% | 0.0 |
| MeVP63 (L) | 1 | GABA | 1.5 | 0.1% | 0.0 |
| aMe9 (R) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| MeVPMe11 (R) | 1 | Glu | 1.5 | 0.1% | 0.0 |
| DNp27 (L) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| l-LNv (R) | 2 | unc | 1.5 | 0.1% | 0.3 |
| PLP131 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| 5thsLNv_LNd6 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP25 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP96 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPaMe1 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Lat3 (L) | 2 | unc | 1 | 0.1% | 0.0 |
| aMe20 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| 5-HTPMPV01 (R) | 1 | 5-HT | 1 | 0.1% | 0.0 |
| AVLP531 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| Cm26 (L) | 2 | Glu | 1 | 0.1% | 0.0 |
| MeVC23 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| CB0656 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| TmY14 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| aMe8 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| LoVP58 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| aMe26 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| LO_unclear (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVP3 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| OCG02c (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP7 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP21 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| CL083 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| SMP200 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVC21 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe4 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| DNpe021 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP29 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 0.5 | 0.0% | 0.0 |
| DNc02 (R) | 1 | unc | 0.5 | 0.0% | 0.0 |
| aMe17e (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LT43 (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| DNp32 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| MeVC24 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| aMe10 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| LoVP72 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP12 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| CL357 (R) | 1 | unc | 0.5 | 0.0% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 0.5 | 0.0% | 0.0 |
| downstream partner | # | NT | conns aMe1 | % Out | CV |
|---|---|---|---|---|---|
| aMe17c (L) | 2 | Glu | 145.5 | 11.0% | 0.1 |
| CL125 (L) | 2 | Glu | 101 | 7.6% | 0.1 |
| aMe1 (L) | 2 | GABA | 86 | 6.5% | 0.1 |
| aMe6b (L) | 1 | ACh | 85 | 6.4% | 0.0 |
| Lat2 (L) | 2 | unc | 83.5 | 6.3% | 0.1 |
| aMe_TBD1 (L) | 1 | GABA | 73.5 | 5.6% | 0.0 |
| SLP250 (L) | 1 | Glu | 64.5 | 4.9% | 0.0 |
| aMe17e (L) | 1 | Glu | 48 | 3.6% | 0.0 |
| MeVP11 (L) | 17 | ACh | 47.5 | 3.6% | 0.8 |
| SLP249 (L) | 2 | Glu | 47 | 3.5% | 0.1 |
| aMe6c (L) | 2 | Glu | 39 | 2.9% | 0.7 |
| 5thsLNv_LNd6 (L) | 2 | ACh | 33.5 | 2.5% | 0.5 |
| Lat1 (L) | 4 | unc | 33.5 | 2.5% | 0.4 |
| PLP211 (L) | 1 | unc | 29.5 | 2.2% | 0.0 |
| aMe3 (L) | 1 | Glu | 27.5 | 2.1% | 0.0 |
| SMP200 (L) | 1 | Glu | 24.5 | 1.9% | 0.0 |
| DNpe021 (L) | 1 | ACh | 22 | 1.7% | 0.0 |
| MeVP63 (L) | 1 | GABA | 18 | 1.4% | 0.0 |
| aMe20 (L) | 1 | ACh | 17.5 | 1.3% | 0.0 |
| OCG02c (R) | 2 | ACh | 14.5 | 1.1% | 0.6 |
| LoVP96 (L) | 1 | Glu | 14 | 1.1% | 0.0 |
| aMe15 (L) | 1 | ACh | 13.5 | 1.0% | 0.0 |
| aMe8 (L) | 2 | unc | 13.5 | 1.0% | 0.1 |
| MeVC22 (L) | 2 | Glu | 11 | 0.8% | 0.1 |
| l-LNv (L) | 4 | unc | 11 | 0.8% | 0.5 |
| aMe30 (L) | 3 | Glu | 10.5 | 0.8% | 0.5 |
| aMe6a (L) | 1 | ACh | 9.5 | 0.7% | 0.0 |
| SMP217 (L) | 2 | Glu | 9.5 | 0.7% | 0.3 |
| T1 (L) | 1 | HA | 9 | 0.7% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 9 | 0.7% | 0.0 |
| LT58 (L) | 1 | Glu | 8.5 | 0.6% | 0.0 |
| aMe10 (L) | 1 | ACh | 7 | 0.5% | 0.0 |
| DNb05 (L) | 1 | ACh | 7 | 0.5% | 0.0 |
| MeVP4 (L) | 7 | ACh | 7 | 0.5% | 0.5 |
| aMe22 (L) | 1 | Glu | 6.5 | 0.5% | 0.0 |
| aMe_unclear (L) | 1 | Glu | 5 | 0.4% | 0.0 |
| LoVP53 (L) | 1 | ACh | 5 | 0.4% | 0.0 |
| aMe2 (L) | 4 | Glu | 5 | 0.4% | 0.3 |
| aMe5 (L) | 9 | ACh | 5 | 0.4% | 0.3 |
| LoVP54 (L) | 1 | ACh | 4.5 | 0.3% | 0.0 |
| MeVC21 (L) | 3 | Glu | 4.5 | 0.3% | 0.5 |
| PLP074 (L) | 1 | GABA | 4 | 0.3% | 0.0 |
| MeVP29 (L) | 1 | ACh | 3.5 | 0.3% | 0.0 |
| MeLo6 (L) | 2 | ACh | 3.5 | 0.3% | 0.4 |
| aMe26 (L) | 2 | ACh | 3.5 | 0.3% | 0.4 |
| MeVPaMe1 (L) | 1 | ACh | 3.5 | 0.3% | 0.0 |
| MeVP3 (L) | 3 | ACh | 3.5 | 0.3% | 0.5 |
| MeVP1 (L) | 3 | ACh | 3.5 | 0.3% | 0.4 |
| DNp27 (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| aMe13 (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| AVLP531 (L) | 1 | GABA | 3 | 0.2% | 0.0 |
| LoVP38 (L) | 2 | Glu | 3 | 0.2% | 0.3 |
| PLP080 (L) | 1 | Glu | 2.5 | 0.2% | 0.0 |
| PLP174 (L) | 2 | ACh | 2.5 | 0.2% | 0.6 |
| AOTU054 (L) | 1 | GABA | 2.5 | 0.2% | 0.0 |
| PS272 (L) | 1 | ACh | 2.5 | 0.2% | 0.0 |
| aMe12 (L) | 3 | ACh | 2.5 | 0.2% | 0.3 |
| MeLo2 (L) | 3 | ACh | 2.5 | 0.2% | 0.3 |
| aMe4 (L) | 4 | ACh | 2.5 | 0.2% | 0.3 |
| OCG02c (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| CB3141 (L) | 2 | Glu | 2 | 0.2% | 0.5 |
| AOTU055 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| Cm26 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| LoVP50 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| MeVP34 (L) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| Cm24 (L) | 1 | Glu | 1.5 | 0.1% | 0.0 |
| aMe17a (L) | 1 | unc | 1.5 | 0.1% | 0.0 |
| FB8B (L) | 1 | Glu | 1.5 | 0.1% | 0.0 |
| aMe12 (R) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| aMe10 (R) | 2 | ACh | 1.5 | 0.1% | 0.3 |
| MeVPaMe1 (R) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| Pm13 (L) | 1 | Glu | 1.5 | 0.1% | 0.0 |
| PLP256 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe23 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CL269 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPD1b1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP27 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL063 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CB0937 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB3676 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP106 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP73 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP23 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| HBeyelet (L) | 2 | HA | 1 | 0.1% | 0.0 |
| PLP121 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP48 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeLo1 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP17 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LoVC23 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| LoVP58 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| LoVP60 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| LoVP43 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| C2 (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| SMP228 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| CB3001 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| LoVP44 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeLo9 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LC37 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LoVP75 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP_unclear (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| aMe24 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| CL083 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP50 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| aMe17b (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| LoVCLo2 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| MeVP49 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LPT60 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| LoVCLo3 (L) | 1 | OA | 0.5 | 0.0% | 0.0 |
| MeVPMe12 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP26 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 0.5 | 0.0% | 0.0 |
| PLP066 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| SMP245 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Lat3 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| Cm23 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| ExR5 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Lat4 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| LoVC19 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| LoVC20 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeVCMe1 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |